Post-IPO Equity - Outlook Therapeutics - Dec 23, 2022 Funding Round Profile - Cointime

Bitcoin $87,587.33 -0.30%
Ethereum $3,226.21 -2.96%
BNB $611.20 -6.21%
Optimism $1.59 -11.52%
Arbitrum $0.61 -8.99%
Solana $204.68 -6.99%
Polygon $0.38 -9.38%
Cosmos $5.06 -10.03%
Avalanche $32.72 -8.77%

Bitcoin $87,587.33 -0.30%
Ethereum $3,226.21 -2.96%
BNB $611.20 -6.21%
Optimism $1.59 -11.52%
Arbitrum $0.61 -8.99%
Solana $204.68 -6.99%
Polygon $0.38 -9.38%
Cosmos $5.06 -10.03%
Avalanche $32.72 -8.77%

Outlook Therapeutics

company

Funding Round

Post-IPO Equity

Money Raised

$ 25M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
GMS Holdings	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 22, 2022	Post-IPO Debt	$ 6.80M		Detail
May 26, 2020	Post-IPO Equity	$ 27.20M	Syntone Ventures	Detail
Jul 27, 2015	Series Unknown	$ 31M	Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc.	Detail
Nov 5, 2018	Post-IPO Equity	$ 20M	Biolexis	Detail
Nov 29, 2021	Post-IPO Equity	$ 57.50M		Detail
Jan 29, 2021	Post-IPO Equity	$ 35M		Detail
Feb 16, 2021	Post-IPO Equity	$ 42.60M		Detail
Sep 29, 2015	Series Unknown	0	Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc.	Detail
Feb 24, 2020	Post-IPO Equity	$ 10.20M		Detail
May 14, 2018	Post-IPO Equity	$ 15M	GMS Tenshi Holdings	Detail
May 13, 2016	IPO	$ 35M		Detail